Bromadol BDPC, the recently created opioid, exhibits peculiar pharmacological properties. It primarily works as an limited mu-opioid receptor agonist, however demonstrates notable influence on a kappa receptor while too. This mixed influence produces in a complex set of impacts, like pain reduction, drowsiness, plus possibly respiratory slowdown